These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35311434)

  • 21. [Pericarditis].
    Marques C; Cacoub P
    Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis.
    Affas ZR; Rasool BQ; Sebastian SA; Affas RS; Mohamadtahr SK; Saoor NH; Mohammad AN; Saoor GH; Husain BA; Touza R; Touza G; Amen S; Nazzaro W
    Cureus; 2022 Nov; 14(11):e31226. PubMed ID: 36505131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin-1.
    Del Buono MG; Bonaventura A; Vecchié A; Moroni F; Golino M; Bressi E; De Ponti R; Dentali F; Montone RA; Kron J; Lazzerini PE; Crea F; Abbate A
    Eur J Clin Invest; 2024 Feb; 54(2):e14110. PubMed ID: 37837616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Trials in Pericardial Disease: New Paradigm Shift.
    Imazio M
    Curr Cardiol Rep; 2021 Oct; 23(11):170. PubMed ID: 34633515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis.
    Melendo-Viu M; Marchán-Lopez Á; Guarch CJ; Roubín SR; Abu-Assi E; Meneses RT; Ynsaurriaga FA; Hernandez AV; Bueno H
    Trends Cardiovasc Med; 2023 Jul; 33(5):319-326. PubMed ID: 35131416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors.
    Lo Presti S; Elajami TK; Reyaldeen R; Anthony C; Imazio M; Klein AL
    J Am Heart Assoc; 2021 Oct; 10(19):e021685. PubMed ID: 34569270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
    Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Therapeutic Insights Into the Treatment of Pericarditis: Targeting the Innate Immune System.
    Vecchié A; Bonaventura A; Golino M; Thomas G; Abbate A
    J Cardiovasc Pharmacol; 2024 May; 83(5):377-383. PubMed ID: 38422218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent pericarditis: new and emerging therapeutic options.
    Imazio M; Lazaros G; Brucato A; Gaita F
    Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
    Schwier NC
    Ann Pharmacother; 2022 May; 56(5):572-581. PubMed ID: 34459270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.
    Dong T; Klein AL; Wang TKM
    Curr Cardiol Rep; 2023 Sep; 25(9):993-1000. PubMed ID: 37458866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.
    Pappritz K; Lin J; El-Shafeey M; Fechner H; Kühl U; Alogna A; Spillmann F; Elsanhoury A; Schulz R; Tschöpe C; Van Linthout S
    ESC Heart Fail; 2022 Apr; 9(2):925-941. PubMed ID: 35178861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
    Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
    Front Immunol; 2018; 9():1233. PubMed ID: 29910817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in medical therapy for pericardial diseases.
    Galluzzo A; Imazio M
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):635-643. PubMed ID: 30103638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.
    Klein AL; Imazio M; Brucato A; Cremer P; LeWinter M; Abbate A; Lin D; Martini A; Beutler A; Chang S; Fang F; Gervais A; Perrin R; Paolini JF
    Am Heart J; 2020 Oct; 228():81-90. PubMed ID: 32866928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pericarditis: Update on diagnosis and management.
    Ismail TF
    Clin Med (Lond); 2020 Jan; 20(1):48-51. PubMed ID: 31941732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
    Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
    Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
    Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy update of acute idiopathic pericarditis.
    Schwier NC; Coons JC; Rao SK
    Pharmacotherapy; 2015 Jan; 35(1):99-111. PubMed ID: 25630413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.